ASA supports policies that promote access to safe and effective pain care and has a significant interest in reducing the misuse, abuse, and diversion of opioid medications that have led to unintended deaths. ASA collaborates with other societies and government entities to further these efforts.
National Pain Strategy
A 2011 report by the Institute of Medicine (IOM), Relieving Pain in America: A Blueprint for Transforming Prevention, Care Education, and Research, called for a cultural transformation in pain prevention, care, education, and research and recommended development of a comprehensive population health-level strategy to address these issues. This report led to the development of the Interagency Pain Research Coordinating Committee (IPRCC) at the National Institutes of Health (NIH) and the draft National Pain Strategy.
The (IPRCC) was charged with creating a comprehensive population health level strategy for pain prevention, treatment, management, and research. The draft National Pain Strategy was released in April 2015.
Learn more about the IOM report, the National Pain Strategy and ASA action:
Pain Care Coalition (PCC)
The Pain Care Coalition is comprised of the American Academy of Pain Medicine, the American Pain Society, and ASA. The coalition works together to support policies to further responsible pain care.
Collaborative Efforts of the PCC:
American Medical Association (AMA) Task Force to Reduce Prescription Opioid Abuse
ASA is a member of the AMA Task Force, comprised of more than 25 state, specialty and other health care associations, working together to reduce prescription drug abuse. The Task Force recognizes that physicians are key to implementing recommendations to reduce the nation’s burden of prescription drug abuse and offers resources for both physicians and the public.
The goals of the Task Force are to:
- Increase physicians' registration and use of effective prescription drug monitoring programs
- Enhance physicians' education on effective, evidence-based prescribing
- Reduce the stigma of pain and promote comprehensive assessment and treatment
- Reduce the stigma of substance use disorder and enhance access to treatment
- Expand access to naloxone in the community and through co-prescribing
Stakeholders’ Challenges and Red Flag Warning Signs Related to Prescribing and Dispensing Controlled Substances
A group of organizations, including ASA, representing the spectrum of medical and pharmacist care, as well as the supply chain, worked together to develop a consensus document (PDF) with the goal of addressing prescription drug abuse and patient access to prescription opioids. The document details the challenges faced by all involved, highlighting red flag warning signs for physicians and pharmacists to detect diversion, misuse, and abuse of controlled substance medications, and identifying aberrant behavior indicators.
Government Initiatives: Learn about what Congress, Federal agencies, and the administration are doing to combat the prescription drug abuse epidemic.